KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Long-Term Deferred Tax: 2009-2025

Historic Long-Term Deferred Tax for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Sep 2025 value amounting to $1.6 billion.

  • Teva Pharmaceutical Industries' Long-Term Deferred Tax fell 21.06% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 21.06%. This contributed to the annual value of $1.8 billion for FY2024, which is 0.72% down from last year.
  • As of Q3 2025, Teva Pharmaceutical Industries' Long-Term Deferred Tax stood at $1.6 billion, which was down 8.25% from $1.8 billion recorded in Q2 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Long-Term Deferred Tax peaked at $2.1 billion during Q3 2024, and registered a low of $596.0 million during Q4 2021.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Long-Term Deferred Tax value was $1.8 billion (recorded in 2025), while the average stood at $1.8 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Long-Term Deferred Tax spiked by 148.55% in 2022 and then fell by 21.06% in 2025.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Long-Term Deferred Tax stood at $596.0 million in 2021, then soared by 144.63% to $1.5 billion in 2022, then climbed by 24.28% to $1.8 billion in 2023, then dropped by 0.72% to $1.8 billion in 2024, then declined by 21.06% to $1.6 billion in 2025.
  • Its Long-Term Deferred Tax stands at $1.6 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.8 billion for Q1 2025.